Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor - Ammollo, C T; Semeraro, F; Incampo, F; Semeraro, N; Colucci, M (J Thromb Haemost, 2010)